Researchers at the University of California, Davis have developed a sustainable alternative to Portland cement by utilizing alkali-activated binders (AAB) with biomass ash, significantly reducing greenhouse gas emissions.

Researchers at the University of California, Davis has developed a microRNA-based treatment for traumatic brain injury.

Researchers at the University of California, Davis have developed a technology that significantly improves the timing and spatial resolution of PET scans using dual-ended readout detectors.

Researchers at the University of California, Davis have developed a reversed feedback amplifier design for enhanced mm-wave signal amplification.

Researchers at the University of California, Davis have developed H2CBD, a fully synthetic analog of CBD designed to treat seizures without the psychoactive effects associated with Cannabis.

Researchers at the University of California, Davis have developed an approach to combat Feline Infectious Peritonitis (FIP) through an in vitro-transcribed (IVT) RNA vaccine targeting the FCoV nucleocapsid (N) protein antigen.

Please view this family of technologies HERE

Researchers at the University of California, Davis, have developed a monoclonal antibody for treating and diagnosing T cell lymphoma in dogs as well as monoclonal antibodies targeting c-KIT for treating and diagnosing mast cell tumors in dogs.